For the majority of cancer survivors, the door to simplified issue life insurance, term coverage, permanent coverage, meaningful amounts, opens well before the ten-year mark. What carriers are measuring is time since the end of treatment. That clock is often further along than people realise.
Beyond one year since treatment completion, both term and permanent coverage are typically available through simplified issue products. Coverage amounts that can exceed $300,000 are accessible for many survivors in remission. The type of cancer matters less than when treatment ended.
Why do most cancer survivors assume coverage is off the table?
Cancer survivors tend to assume two things about life insurance: that a cancer history automatically disqualifies them, and that if coverage exists at all, it must be expensive or limited to something barely worth having. Both assumptions are wrong often enough that they're worth examining directly.
Simplified issue life insurance, the kind you apply for by answering health questions with no medical exam, no clinic visit, no blood draw, is the main product category available to Canadians with pre-existing health histories. And cancer history, for most survivors beyond the first year of remission, does not remove you from that category.
What determines eligibility is a set of health questions every carrier asks. One of those questions looks at cancer history. Specifically, it looks at whether you have been diagnosed with, treated for, or investigated for cancer within a certain time window. Once you're outside that window, the question no longer applies to you in a meaningful way. You answer honestly, the application moves forward, and coverage is typically available.
Carriers are not looking at your cancer history as evidence of ongoing risk. They're looking at whether the event is recent enough to create uncertainty about your current health status. Past that window, a cancer history in remission is often treated very similarly to other well-managed chronic conditions.
What does the remission clock actually measure?
Here's the piece that trips people up most often. When carriers look at cancer history, the timing they care about runs from the end of treatment, not from when you were first diagnosed.
Someone diagnosed in 2017 who went through surgery and chemotherapy finishing in 2019 is not seven years removed from their cancer history. They are five years removed. The clock started when treatment ended, not when the diagnosis came.
That distinction matters practically. A lot of survivors count from diagnosis and conclude they're well past any relevant window, when the actual timing is shorter. Others count from diagnosis and assume they're only a few years out, when in fact they're further along than they think. Either way, the number to know is the date treatment completed: the last chemotherapy session, the last radiation treatment, the last surgery tied to the cancer. That is the date that governs.
Basal cell carcinoma, the most common form of skin cancer typically treated with a minor procedure, is excluded from cancer questions entirely. If your only cancer history is basal cell, it does not affect your simplified issue application at all.
The clock runs from the end of treatment, not from the original diagnosis. Count from your last chemotherapy, radiation, or cancer-related surgery. That is the date carriers are actually measuring from.
What does coverage look like at each stage of remission?
The coverage picture changes as time passes. Here's how it generally works across the windows carriers look at.
Time since end of treatment
Coverage typically available
Structure
Within 12 months
Lower ceiling applies
Permanent only, waiting period applies. See Part 1 of this series.
1 to 10 years, in remission
Moderate to full simplified issue amounts
Both term and permanent typically available; some carriers may include a partial deferral period in early years; coverage amounts improve with time
Beyond 10 years in remission
Full simplified issue amounts
Both term and permanent available; amounts up to $500,000 or more typical for most applicants; rates closer to standard simplified issue pricing
All figures are illustrative. Actual coverage and premiums depend on your health profile, the specific insurer, and the product applied for. Speak with a licensed advisor for figures specific to your situation.
The 1-to-10-year window is where most cancer survivors reading this article will find themselves. Within that range, simplified issue coverage is typically accessible. The amounts available in the earlier years of that window tend to be lower, and some carriers apply a partial deferral period, meaning there is a short period at the start of the policy where only a portion of the death benefit is payable for non-accidental causes. Accidental death is generally covered from day one even where a deferral applies.
As years pass in remission, coverage conditions generally improve. A survivor who was offered one set of terms at three years post-treatment may find meaningfully better terms, higher amounts, lower premiums, no deferral, at seven or eight years. An application turned down two years ago is worth revisiting.
Beyond the ten-year mark, for many applicants the cancer history stops being the governing factor in the application. Coverage at full simplified issue amounts, up to $500,000 or more depending on age and insurer, becomes typical. A licensed advisor can confirm where a specific history falls and what the options look like.
Does the type of cancer matter to underwriters?
For the most common cancer types, breast, prostate, colon, bladder, thyroid, early-stage lung, lymphoma, the type of cancer is generally less determinative than the timing. Two applicants with different cancer histories but the same remission timeline will often see similar results from the underwriting question set.
This surprises people. The assumption is that some cancers disqualify and others don't. In simplified issue underwriting, the question is structured around recency and current status, not around a hierarchy of cancer types. "Have you been diagnosed with, treated for, or investigated for cancer in the last X years?" covers all cancer types the same way.
There are exceptions. Metastatic cancer and recurrent cancer produce a different outcome that falls outside simplified issue eligibility regardless of timing. Cancers with very high ongoing risk profiles may be assessed differently by individual carriers. And certain cancer types that are more commonly associated with recurrence may prompt additional questions depending on the insurer and the specific product.
Basal cell carcinoma, worth repeating here because it comes up so often, is excluded from cancer questions altogether. It does not appear in simplified issue health question sets and does not affect eligibility.
For most survivors with a common cancer type in confirmed remission, the type of cancer is a secondary consideration. The date treatment ended is the number that matters most.
What changes the picture: recurrence and pending investigations
Two situations shift the outcome significantly, and both are worth understanding before applying.
Recurrence or metastasis. If cancer returned at any point, or spread to other parts of the body, that history places you outside simplified issue eligibility regardless of how long ago it happened. Guaranteed acceptance permanent coverage is still available: no health questions, acceptance guaranteed within the eligible age range, and a known structure from the first day. It is sized for final expense purposes, not income replacement. If you're in this situation, Part 3 of this series covers it directly: Life Insurance With Metastatic or Recurrent Cancer .
A pending investigation with an unknown result. If you are currently waiting for the result of a biopsy, imaging, or any cancer-related diagnostic test, the right move is to wait before applying. Simplified issue applications ask whether you have had any investigations with results pending. If the answer is yes, that alone is enough to trigger a temporary hold on eligibility. Once results are back and you know where you stand, the picture becomes clear. The pending test results article covers this in detail, but the short version is: applying while something is unresolved almost always produces a worse outcome than waiting for clarity.
If you have a biopsy, scan, or cancer-related investigation with results still pending, wait before submitting an application. Applying while results are unknown typically produces a worse outcome than waiting a few weeks for the result to come back. A licensed advisor can help you time this correctly.
What do you need to disclose on the application?
Every simplified issue application is built on honest, accurate answers to health questions. Not because carriers are trying to catch applicants out, but because the coverage terms you receive, the premium, the waiting period, the coverage amount, are set based on your disclosed health history. If that disclosure is inaccurate, the insurer has grounds to void the policy or deny a claim.
That consequence falls on the people a policy is meant to protect. A claim denied years down the road because of a disclosure problem discovered after the fact is a very bad outcome for a beneficiary. Accuracy at application isn't paperwork. It's how the policy works when it's supposed to.
Practically, this means being clear about treatment dates. Not a rough year. An actual date or at minimum a month and year. The difference between "about five years ago" and "June 2021" matters when the answer determines which window applies. If you're not certain of the exact date, your oncologist's records or your family doctor's file will have it.
A licensed advisor can help you understand how your specific history maps to the questions being asked before you apply. That conversation is worth having, both to confirm timing and to make sure the application reflects your history accurately.
What to bring to the conversation
If you've been in remission for more than a year and haven't looked at coverage recently, the first useful step is knowing your treatment end date. Not the diagnosis date. The date treatment completed.
From there, the conversation with a licensed advisor becomes specific quickly. With that date confirmed, they can tell you which simplified issue products are currently available to you, what amounts are typical at your remission timeline, and whether any partial deferral period applies. What they cannot do, and should not do, is estimate based on approximations. The more precise the history, the cleaner the answer.
Beyond the health history, the other number worth knowing before that conversation is the monthly premium you are completely comfortable paying regardless of what happens next. Not the coverage amount you want to leave your family, not a number you've arrived at from some rule of thumb. The premium you know you'll sustain. Coverage amount follows from what that premium can buy at your age and current eligibility. Arriving at that number first keeps the policy in force, which is the whole point.
This article is for educational purposes only and does not constitute insurance advice. Eligibility, premiums, and coverage terms vary by individual health profile and insurer. Speak with a licensed Canadian insurance advisor before making any coverage decision. Reviewed by a licensed Canadian insurance professional.